Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib.

Auteurs : Kourie HR, El Rassy E, Clatot F, de Azambuja E, Lambertini M
Jaar : 2017
Journal : Onco Targets Ther
Volume : 10
Pagina's : 3363-3372